🇺🇸 FDA
Patent

US 9303087

Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof

granted A61KA61K2039/505A61K39/3955

Quick answer

US patent 9303087 (Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof) held by The Board of Regents of the University of Oklahoma expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
92
CPC classes
A61K, A61K2039/505, A61K39/3955, A61K45/06, A61K9/0048